286 results
Page 2 of 15
8-K
EX-10.1
g1dy8oh0fm4 yi
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
fwaqp4uq1
13 Sep 23
Entry into a Material Definitive Agreement
9:01am
8-K/A
EX-10.1
mf0fm3z
6 Sep 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
qu7zght19 d083u3udq
17 Aug 23
ABVC Executes Cooperation Agreement for Strategic Investments
8:33am
8-K
EX-10.1
7gv226h1ge9v2t
2 Aug 23
ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales
5:00pm
8-K
EX-10.1
cwaeg8w k0x1
27 Jul 23
Entry into a Material Definitive Agreement
9:14am
8-K
EX-10.1
mdaism4nrv8vhtjkyc4
23 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.6
8hkhxruhoxye0fe4h4i
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.2
or6 shaksrnvlf9u1
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.9
18yi9i67
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.7
fhz4513jx668xr5
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.3
dshbwx
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.10
7no9sa 0vfii7g12
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.1
abq6k3
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.4
2o72372pyw20e1m h0
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.11
fsm 7ow690qyttg
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.5
vdu41zm
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm